Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer

US Patent 9095601 · Granted Aug 4, 2015

Assignee

Inventors

View full patent text on Google Patents →